Curtin University Homepage
  • Library
  • Help
    • Admin

    espace - Curtin’s institutional repository

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item

    A descriptive model of patient readiness, motivators, and hepatitis C treatment uptake among Australian prisoners

    199199_116918_YapCARRUTHERSJONESDescriptivePlose87564.pdf (283.3Kb)
    Access Status
    Open access
    Authors
    Yap, L.
    Carruthers, Susan
    Thompson, S.
    Cheng, W.
    Jones, J.
    Simpson, P.
    Richards, A.
    Thein, H.
    Haber, P.
    Lloyd, A.
    Butler, Tony
    Date
    2014
    Type
    Journal Article
    
    Metadata
    Show full item record
    Citation
    Yap, L. and Carruthers, S. and Thompson, S. and Cheng, W. and Jones, J. and Simpson, P. and Richards, A. et al. 2014. A descriptive model of patient readiness, motivators, and hepatitis C treatment uptake among Australian prisoners. PLoS ONE. 9 (2): pp. e87564-1 – e87564-11.
    Source Title
    PLoS ONE
    DOI
    10.1371/journal.pone.0087564
    ISSN
    19326203
    Remarks

    This article is published under the Open Access publishing model and distributed under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ Please refer to the licence to obtain terms for any further reuse or distribution of this work.

    URI
    http://hdl.handle.net/20.500.11937/27266
    Collection
    • Curtin Research Publications
    Abstract

    Background: Hepatitis C virus infection (HCV) has a significant global health burden with an estimated 2%–3% of the world's population infected, and more than 350,000 dying annually from HCV-related conditions including liver failure and liver cancer. Prisons potentially offer a relatively stable environment in which to commence treatment as they usually provide good access to health care providers, and are organised around routine and structure. Uptake of treatment of HCV, however, remains low in the community and in prisons. In this study, we explored factors affecting treatment uptake inside prisons and hypothesised that prisoners have unique issues influencing HCV treatment uptake as a consequence of their incarceration which are not experienced in other populations. Method and Findings: We undertook a qualitative study exploring prisoners' accounts of why they refused, deferred, delayed or discontinued HCV treatment in prison. Between 2010 and 2013, 116 Australian inmates were interviewed from prisons in New South Wales, Queensland, and Western Australia. Prisoners experienced many factors similar to those which influence treatment uptake of those living with HCV infection in the community. Incarceration, however, provides different circumstances of how these factors are experienced which need to be better understood if the number of prisoners receiving treatment is to be increased. We developed a descriptive model of patient readiness and motivators for HCV treatment inside prisons and discussed how we can improve treatment uptake among prisoners.Conclusion: This study identified a broad and unique range of challenges to treatment of HCV in prison. Some of these are likely to be diminished by improving treatment options and improved models of health care delivery. Other barriers relate to inmate understanding of their illness and stigmatisation by other inmates and custodial staff and generally appear less amenable to change although there is potential for peer-based education to address lack of knowledge and stigma.

    Related items

    Showing items related by title, author, creator and subject.

    • Acceptability of prison-based take-home naloxone programmes among a cohort of incarcerated men with a history of regular injecting drug use
      Curtis, M.; Dietze, P.; Aitken, C.; Kirwan, A.; Kinner, S.; Butler, Tony; Stoové, M. (2018)
      Background: Take-home naloxone (THN) programmes are an evidence-based opioid overdose prevention initiative. Elevated opioid overdose risk following prison release means release from custody provides an ideal opportunity ...
    • Social capital strategies to enhance hepatitis C treatment awareness and uptake among men in prison
      Lafferty, L.; Treloar, C.; Guthrie, J.; Chambers, G.; Butler, Tony (2017)
      © 2016 John Wiley & Sons Ltd Prisoner populations are characterized by high rates of hepatitis C (HCV), up to thirty times that of the general population in Australia. Within Australian prisons, less than 1% of eligible ...
    • Study protocol: Hybrid Type I cost-effectiveness and implementation study of interpersonal psychotherapy (IPT) for men and women prisoners with major depression
      Johnson, J.; Miller, Ted; Stout, R.; Zlotnick, C.; Cerbo, L.; Andrade, J.; Wiltsey-Stirman, S. (2016)
      © 2016 Elsevier Inc. Purpose: This article describes the protocol for a Hybrid Type I cost-effectiveness and implementation study of interpersonal psychotherapy (IPT) for men and women prisoners with major depressive ...
    Advanced search

    Browse

    Communities & CollectionsIssue DateAuthorTitleSubjectDocument TypeThis CollectionIssue DateAuthorTitleSubjectDocument Type

    My Account

    Admin

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Follow Curtin

    • 
    • 
    • 
    • 
    • 

    CRICOS Provider Code: 00301JABN: 99 143 842 569TEQSA: PRV12158

    Copyright | Disclaimer | Privacy statement | Accessibility

    Curtin would like to pay respect to the Aboriginal and Torres Strait Islander members of our community by acknowledging the traditional owners of the land on which the Perth campus is located, the Whadjuk people of the Nyungar Nation; and on our Kalgoorlie campus, the Wongutha people of the North-Eastern Goldfields.